A comparative study of shock wave therapy and corticosteroid injection in the treatment of heel pain

A prospective comparative study of Extracorporeal Shock Wave and Corticosteroid injection in the treatment of plantar fasciitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201203069221N1

Enrollment

Registered

2012-04-11

Start date

2011-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fasciitis. Fibroblastic disorders

Interventions

Intervention 1: 3 sessions of 2000 pulses, 2.5 bar 10 Hz shock wave therapy. Intervention 2: 40 mg of methyl prednisolone and 2 cc lidocain 2% injection.

Treatment - Other

Treatment - Drugs

3 sessions of 2000 pulses, 2.5 bar 10 Hz shock wave therapy

40 mg of methyl prednisolone and 2 cc lidocain 2% injection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.age more than 18; heel pain more than 4 weeks; nonresponsive to conservative treatments; pain intensity more than 2 in VAS; no evidence of calcaneal FX; patients be able to follow the study for 3 months after intervention. Exclusion criteria: heel surgery; nerve injury or achillis tendon injury. RA, DM, local infection, systemic infection, pripheral vascular disease, coagulation disorders, CRPS, pregnancy, breast feeding, corticosteroid injection in the last 6 months or NSAIDS consumption in the last 7 days; history of sensitivity to injection solution.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain in standing and morning pain. Timepoint: before intervention ,1 week ,1 and 3 months after intervention. Method of measurement: visual analog scale (VAS) which is from 0 (no pain) to 10 (very severe pain).	—

Secondary

Measure	Time frame
Ameliorating in ADL and sportive activity. Timepoint: befor intervention, 1 week, 1 and 3 months after intervention. Method of measurement: visual analog scale foot and ankle (VASFA) which is from 0 (compeletly impaired) to 100(normal).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafiseh Maleki

Army University of Medical Sciences

mnafism@yahoo.com+98 21 8595 3476

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026